AMENDMENT TO LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTLicense, Development, and Commercialization Agreement • May 13th, 2008 • ARYx Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Amendment to License, Development, and Commercialization Agreement (the “Amendment”) is entered into this 29th day of February, 2008, (the “Amendment Effective Date”) by and between ARYx Therapeutics, Inc., a Delaware corporation having offices at 6300 Dumbarton Circle, Fremont, CA 94555 (“ARYx”), and Procter & Gamble Pharmaceuticals, Inc., an Ohio corporation having offices at One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (“P&G”).
